FDA tentatively approves generic version of pediatric HIV drug under PEPFAR program
The FDA on Tuesday tentatively approved a pediatric version of an HIV-1 treatment following a successful public-private partnership between the Clinton Health Access Initiative, Unitaid …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.